Do you want to read an article? Please log in or register.
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models
Further Publications NeurologyFurther Publications Psychiatry
Related content
Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis
Neurology.
Scheibe F, Prüss H, Mengel AM, Kohler S, Nümann A, Köhnlein M, Ruprecht K, Alexander T, Hiepe F, Meisel A
doi: 10.1212/
Further Publications NeurologyFurther Publications Psychiatry
NMDA receptor antagonists and pain relief: A meta-analysis of experimental trials
Neurology.
Thompson T, Whiter F, Gallop K, Veronese N, Solmi M, Newton P, Stubbs B
doi: 10.1212/WNL.
Psychosis and Schizophrenia
Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients
Nat Commun.
Jézéquel J, Johansson EM Dupuis JP, Rogemond V, Gréa H, Kellermayer B, Hamdani N, Le Guen E, Rabu C, Lepleux M Spatola M, Mathias E, Bouchet D, Ramsey AJ, Yolken RH, Tamouza R, Dalmau J, Honnorat J, Leboyer M, Groc L
doi: 10.1038/
RECOMMENDED
Further Publications NeurologyFurther Publications Psychiatry
Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis
★ 1
Recommended by
Prof. Dr Christian Kamm, Faculty Member
J Neurol.
Scheibe F, Ostendorf L, Reincke SM, Prüss H, von Brünneck AC, Köhnlein M, Alexander T, Meisel C, Meisel A
doi: 10.1007/s00415-019-09585-6.
Anxiety and Depression
Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior
Biol Psychiatry
Chen BK, Luna VM, Shannon ME, Hunsberger HC, Mastrodonato A, Stackmann M, McGowan JC, Rubinstenn G, Denny CA
doi: 10.1016/j.biopsych.2021.04.024
RECOMMENDED
Psychosis and Schizophrenia
Potential Mechanisms for the Ketamine-Induced Reduction of P3b Amplitudes
Front Behav Neurosci.
Rosburg T, Schmidt A
doi: 10.3389/fnbeh.2018.00308.
Alzheimer’s Disease
N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease
Alzheimers Dement.
Kodis EJ, Choi S, Swanson E, Ferreira G, Bloom GS
doi: 10.1016/j.jalz.2018.05.017.
Psychosis and Schizophrenia
Mechanism of action of pimavanserin in Parkinson's disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors
CNS Spectr.
Stahl SM
doi: 10.1017/
Epilepsy
Seizures in autoimmune encephalitis-A systematic review and quantitative synthesis
Epilepsia
Yeshokumar AK, Coughlin A, Fastman J, Psaila K, Harmon M, Randell T, Schorr EM, Han H, Hoang H, Soudant C, Jette N
doi: 10.1111/epi.16807